These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 25640943)

  • 41. Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells.
    Jagadeeswaran R; Jagadeeswaran S; Bindokas VP; Salgia R
    Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1488-94. PubMed ID: 17322284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
    Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic gene expression of NK4, an HGF-antagonist/angiogenesis inhibitor, suppresses liver metastasis and invasive growth of colon cancer in mice.
    Wen J; Matsumoto K; Taniura N; Tomioka D; Nakamura T
    Cancer Gene Ther; 2004 Jun; 11(6):419-30. PubMed ID: 15017381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nude mouse model of human gastric carcinoma metastasis constructed by orthotopic transplantation using organism glue paste technique].
    Chen YL; Wei PK; Xu L; Su XM
    Ai Zheng; 2005 Feb; 24(2):246-8. PubMed ID: 15694045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.
    Firon M; Shaharabany M; Altstock RT; Horev J; Abramovici A; Resau JH; Vande Woude GF; Tsarfaty I
    Oncogene; 2000 May; 19(20):2386-97. PubMed ID: 10828880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection].
    Li Y; Tang Z; Ye S; Liu Y; Chen J; Xue Q; Huang X; Chen J; Bao W; Yang J; Gao D
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):601-5. PubMed ID: 12133480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T; Takayama H; Sharp R; Celli G; LaRochelle WJ; Bottaro DP; Ellmore N; Vieira W; Owens JW; Anver M; Merlino G
    Cancer Res; 1998 Nov; 58(22):5157-67. PubMed ID: 9823327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
    Hoffman RM
    Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC; Gera L; Stewart JM; Helfrich B; Zhao TL; Feng WY; Chan KK; Covey JM; Bunn PA
    Clin Cancer Res; 2002 May; 8(5):1280-7. PubMed ID: 12006549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orthotopic reconstitution of human small-cell lung carcinoma after intravenous transplantation in SCID mice.
    Kuo TH; Kubota T; Watanabe M; Furukawa T; Kase S; Tanino H; Nishibori H; Saikawa Y; Teramoto T; Ihsibiki K
    Anticancer Res; 1992; 12(5):1407-10. PubMed ID: 1332577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
    Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Establishment of a novel orthotopic model of breast cancer metastasis to the lung.
    Guo W; Zhang S; Liu S
    Oncol Rep; 2015 Jun; 33(6):2992-8. PubMed ID: 25963127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a nude mouse orthotopic model of human small cell lung cancer.
    Iochmann S; Lerondel S; Bléchet C; Lavergne M; Pesnel S; Sobilo J; Heuzé-Vourc'h N; Le Pape A; Reverdiau P
    Lung Cancer; 2012 Jul; 77(1):70-6. PubMed ID: 22321610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
    Whang YM; Jung SP; Kim MK; Chang IH; Park SI
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.
    Yang X; Tang C; Luo H; Wang H; Zhou X
    Oncotarget; 2017 Apr; 8(14):23664-23674. PubMed ID: 28423588
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma.
    Adachi E; Sakai K; Nishiuchi T; Imamura R; Sato H; Matsumoto K
    Oncotarget; 2016 Oct; 7(43):70779-70793. PubMed ID: 27683122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Establishment of Dual Fluorescent Labeled Human High Bone Metastasis 
Lung Adenocarcinoma Cell Line and Transcriptomic Characterization Analysis].
    Lu Y; Qiu R; Deng Y; Liu X; Du Y
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):257-265. PubMed ID: 38769828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
    Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
    Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.